Lycia Therapeutics
1 follower
‌
We're building the leading extracellular protein degradation company leveraging our lysosomal targeting chimeras, or LYTAC, platform.
Industries
Headquarters
Employees
Links
Org chart
Aetna Wun Trombley
President & CEO
Aetna Wun Trombley
Collapse
Steve Staben
Chief Scientific Officer
Winsome Chung
VP, Finance
Matt Holdren
Vice President, Nonclinical Development
Larry Rozsnyai
Vice President, Intellectual Property
Nadia Tchao
Executive Director, Head of Translational Medicine & Early Development
Darrin Lindhout
Head of Biologics
Patricia Chang
Associate Director, Project And Alliance Management
